BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23709055)

  • 21. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.
    Strnad V; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Wendt TG; Fietkau R; Hindemith M; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Malzer M; Uter W; Polgár C;
    Lancet; 2016 Jan; 387(10015):229-38. PubMed ID: 26494415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003-2011: report from the national cancer database.
    Yao K; Czechura T; Liederbach E; Winchester DJ; Pesce C; Shaikh A; Winchester DP; Huo D
    Ann Surg Oncol; 2014 Oct; 21(11):3457-65. PubMed ID: 24806115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
    Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
    Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of loco-regional and distant recurrences in breast cancer after conservative surgery.
    Elsayed M; Alhussini M; Basha A; Awad AT
    World J Surg Oncol; 2016 May; 14():144. PubMed ID: 27180041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.
    Gabani P; Cyr AE; Zoberi JE; Ochoa LL; Matesa MA; Thomas MA; Garcia J; Margenthaler JA; Naughton MJ; Ma C; Sanati S; Zoberi I
    Brachytherapy; 2018; 17(1):171-180. PubMed ID: 29089275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
    Mamtani A; Patil S; Stempel MM; Morrow M
    Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excellent Long-term Breast Preservation Rate After Accelerated Partial Breast Irradiation Using a Balloon Device.
    Mann JM; Osian AD; Brandmaier A; Yan W; Sung KJ; Siegel B; Fink S; Kaplan B; Fulman M; Wu G; Christos P; Nori D; Ravi A
    Clin Breast Cancer; 2016 Jun; 16(3):217-22. PubMed ID: 26948247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
    Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer.
    Hieken TJ; Mutter RW; Jakub JW; Boughey JC; Degnim AC; Sukov WR; Childs S; Corbin KS; Furutani KM; Whitaker TJ; Park SS
    Ann Surg Oncol; 2016 Oct; 23(10):3297-303. PubMed ID: 27334215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast conservation therapy utilizing partial breast brachytherapy for early-stage cancer of the breast: a retrospective review from the Saint Luke's Cancer Institute.
    Edwards JM; Herzberg SM; Shook JW; Beirne TK; Schomas DA
    Am J Clin Oncol; 2015 Apr; 38(2):174-8. PubMed ID: 23608831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.
    Horst KC; Fasola C; Ikeda D; Daniel B; Ognibene G; Goffinet DR; Dirbas FM
    Breast; 2016 Aug; 28():178-83. PubMed ID: 27322859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of multicatheter interstitial high-dose-rate brachytherapy for accelerated partial-breast irradiation.
    Gaudet M; Pharand-Charbonneau M; Wright D; Nguyen J; Trudel-Sabourin J; Chelfi M
    Brachytherapy; 2019; 18(2):211-216. PubMed ID: 30554991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avoiding mastectomy: accelerated partial breast irradiation for breast cancer patients with pacemakers or defibrillators.
    Croshaw R; Kim Y; Lappinen E; Julian T; Trombetta M
    Ann Surg Oncol; 2011 Nov; 18(12):3500-5. PubMed ID: 21607774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated partial breast irradiation with interstitial multicatheter brachytherapy after breast-conserving surgery for low-risk early breast cancer.
    Rodriguez-Ibarria NG; Pinar MB; García L; Cabezón MA; Lloret M; Rey-Baltar MD; Rdguez-Melcón JI; Lara PC
    Breast; 2020 Aug; 52():45-49. PubMed ID: 32380439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation.
    Wobb JL; Chen PY; Shah C; Moran MS; Shaitelman SF; Vicini FA; Mbah AK; Lyden M; Beitsch P
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):312-8. PubMed ID: 25446607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of accelerated partial breast irradiation in a large inner-city public hospital.
    Amin M; Gabram S; Bumpers H; Landry J; Jani AB; Diaz R; Rizzo M
    Ann Surg Oncol; 2012 Dec; 19(13):4094-8. PubMed ID: 22732836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
    Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B;
    Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost comparison of radiation treatment options after lumpectomy for breast cancer.
    Greenup RA; Camp MS; Taghian AG; Buckley J; Coopey SB; Gadd M; Hughes K; Specht M; Smith BL
    Ann Surg Oncol; 2012 Oct; 19(10):3275-81. PubMed ID: 22851048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.